| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
|
Ann Clin Microbiol Antimicrob
|
2007
|
3.07
|
|
2
|
Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
|
Psychopharmacology (Berl)
|
2007
|
1.11
|
|
3
|
Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions.
|
Psychopharmacology (Berl)
|
2008
|
0.95
|
|
4
|
Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models.
|
Pharmacol Biochem Behav
|
2011
|
0.91
|
|
5
|
Acute oral dexamethasone administration reduces levels of orphan GPCR glucocorticoid-induced receptor (GIR) mRNA in rodent brain: potential role in HPA-axis function.
|
Brain Res Mol Brain Res
|
2003
|
0.89
|
|
6
|
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
|
Neuropsychopharmacology
|
2008
|
0.87
|
|
7
|
Asenapine effects in animal models of psychosis and cognitive function.
|
Psychopharmacology (Berl)
|
2009
|
0.85
|
|
8
|
Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain.
|
Eur Neuropsychopharmacol
|
2008
|
0.85
|
|
9
|
Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.
|
Psychopharmacology (Berl)
|
2008
|
0.84
|
|
10
|
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
|
Psychopharmacology (Berl)
|
2010
|
0.84
|
|
11
|
Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges.
|
Curr Opin Investig Drugs
|
2008
|
0.83
|
|
12
|
Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain.
|
J Mol Neurosci
|
2010
|
0.82
|
|
13
|
The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats.
|
Behav Pharmacol
|
2009
|
0.82
|
|
14
|
Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.
|
Synapse
|
2010
|
0.82
|
|
15
|
Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
|
Neuropharmacology
|
2011
|
0.82
|
|
16
|
The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action.
|
Pharmacol Ther
|
2010
|
0.81
|
|
17
|
Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus.
|
Psychopharmacology (Berl)
|
2009
|
0.80
|
|
18
|
Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.
|
Eur J Pharmacol
|
2008
|
0.80
|
|
19
|
Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.
|
J Psychopharmacol
|
2010
|
0.80
|
|
20
|
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
|
Behav Brain Res
|
2010
|
0.80
|
|
21
|
Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
|
Psychopharmacology (Berl)
|
2009
|
0.80
|
|
22
|
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576.
|
Psychopharmacology (Berl)
|
2011
|
0.80
|
|
23
|
Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
|
Int J Neuropsychopharmacol
|
2009
|
0.80
|
|
24
|
Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.
|
J Mol Neurosci
|
2009
|
0.79
|
|
25
|
SleepAp: an automated obstructive sleep apnoea screening application for smartphones.
|
IEEE J Biomed Health Inform
|
2015
|
0.79
|
|
26
|
Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.
|
Neuropharmacology
|
2005
|
0.79
|
|
27
|
Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain.
|
Synapse
|
2009
|
0.78
|
|
28
|
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.
|
Drugs Today (Barc)
|
2009
|
0.77
|
|
29
|
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
|
Biol Psychiatry
|
2012
|
0.77
|
|
30
|
The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus.
|
Pharmacol Res
|
2011
|
0.76
|
|
31
|
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
|
Psychopharmacology (Berl)
|
2011
|
0.76
|
|
32
|
The α2C-adrenoceptor antagonist, ORM-10921, exerts antidepressant-like effects in the Flinders Sensitive Line rat.
|
Behav Pharmacol
|
2016
|
0.75
|
|
33
|
Compatibility of electroanatomical mapping systems with a concurrent percutaneous axial flow ventricular assist device.
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|